A Budget Impact Model for the Introduction of Bevacizumab for the Treatment of Newly Diagnosed Glioblastoma Multiforme in the UK
May 1, 2014, 00:00 AM
10.1016/j.jval.2014.03.440
https://www.valueinhealthjournal.com/article/S1098-3015(14)00491-4/fulltext
Section Title :
Cancer
Section Order :
1486
First Page :
A75
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00491-4&doi=10.1016/j.jval.2014.03.440